UA100553C2 - Method for the assessment of therapeutic effectiveness of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventricular hypertrophy and diastolic dysfunction - Google Patents

Method for the assessment of therapeutic effectiveness of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventricular hypertrophy and diastolic dysfunction

Info

Publication number
UA100553C2
UA100553C2 UAA201012691A UAA201012691A UA100553C2 UA 100553 C2 UA100553 C2 UA 100553C2 UA A201012691 A UAA201012691 A UA A201012691A UA A201012691 A UAA201012691 A UA A201012691A UA 100553 C2 UA100553 C2 UA 100553C2
Authority
UA
Ukraine
Prior art keywords
stenocardia
isradipine
patients
assessment
arterial hypertension
Prior art date
Application number
UAA201012691A
Other languages
Russian (ru)
Ukrainian (uk)
Inventor
Михаил Васильевич Бычко
Ярослав Михайлович Бычка
Original Assignee
Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет" filed Critical Государственное Высшее Учебное Заведение "Ужгородский Национальный Университет"
Priority to UAA201012691A priority Critical patent/UA100553C2/en
Publication of UA100553C2 publication Critical patent/UA100553C2/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The invention relates to medicine, in particular to cardiology, and can be used for objective assessment of antianginal effect of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventriculardiastolic dysfunction.
UAA201012691A 2010-10-26 2010-10-26 Method for the assessment of therapeutic effectiveness of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventricular hypertrophy and diastolic dysfunction UA100553C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UAA201012691A UA100553C2 (en) 2010-10-26 2010-10-26 Method for the assessment of therapeutic effectiveness of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventricular hypertrophy and diastolic dysfunction

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UAA201012691A UA100553C2 (en) 2010-10-26 2010-10-26 Method for the assessment of therapeutic effectiveness of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventricular hypertrophy and diastolic dysfunction

Publications (1)

Publication Number Publication Date
UA100553C2 true UA100553C2 (en) 2013-01-10

Family

ID=51583881

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA201012691A UA100553C2 (en) 2010-10-26 2010-10-26 Method for the assessment of therapeutic effectiveness of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventricular hypertrophy and diastolic dysfunction

Country Status (1)

Country Link
UA (1) UA100553C2 (en)

Similar Documents

Publication Publication Date Title
UA109650C2 (en) BIS-ARLYZED ARILTRIAZOLONS AND THEIR APPLICATIONS
CL2014003121A1 (en) Liquid formulation comprising propylene glycol and an inodilator, an angiotensin converting enzyme inhibitor or a combination of both; process to prepare it; kit; and method of treatment of heart disease and / or hypertension.
PH12015500407A1 (en) Methods of treating hypertriglyceridemia
EA201200793A1 (en) TREATMENT OF GENOTYPED PATIENTS WITH DIABETES DPP-4 INHIBITORS, SUCH AS LINAGLIPTIN
EA201300669A1 (en) SUBSTITUTED 1-BENZYL CYCLOALKYL CARBONIC ACIDS AND THEIR APPLICATION
EA201491258A1 (en) Self-flashing catheters
UA100553C2 (en) Method for the assessment of therapeutic effectiveness of isradipine in patients with coronary disease with stenocardia and arterial hypertension with left ventricular hypertrophy and diastolic dysfunction
WO2011106378A3 (en) Oral b12 therapy
WO2011127482A3 (en) Modulation of histone deacetylases for the treatment of metabolic disease, methods and compositions related thereto
TR201901012T4 (en) The use of nor-bile acids in the treatment of arteriosclerosis.
WO2012040444A3 (en) Treatment of patients with incipient alzheimer's disease
UA48652U (en) method for evaluation of efficiency of treatment of patients with ischemic heart disease with stenocardia and aarterial hypertensia with Spiraprile
WO2012051165A3 (en) Mir-211 expression and related pathways in human melanoma
UA97739C2 (en) Method for objective estimation of benidipine effect in patients with coronary heart disease accompanied by stenocardia and arterial hypertension with left ventricular hypertrophy
UA47980U (en) Method for assessing treatment efficacy in patients with ischemic heart disease with stenocardia and arterial hypertension
UA47979U (en) Method for assessing treatment efficacy in patients with ischemic heart disease with stenocardia and arterial hypertension
UA107787C2 (en) Method of assessment of the effectiveness of treatment s-metoprolol patients with coronary heart disease with angina and hypertension in violation of left ventricular diastolic function in "hypertrophic" type
UA107786C2 (en) Method of assessment of the effectiveness of treatment s-amplodypinom patients with coronary heart disease with angina and hypertension in violation of left ventricular diastolic function in "hypertrophic" type
UA46854U (en) Method for assessing efficacy of ramipril in treating ischemic heart disease combined with stenocardia and arterial hypertension
UA53584U (en) Method for assessing treatment efficacy of isosorbid dinitrate in patients with ischemic heart disease suffering from angina pectoris and arterial hypertension
UA46855U (en) Method for assessing efficacy of enalapril in treating ischemic heart disease combined with stenocardia and arterial hypertension
UA103369C2 (en) Method for assessment of efficiency of treatment with s-atenolol in patients with stenocardia and arterial hypertensive left ventricular hypertrophy
UA107447C2 (en) Method for assessment of the anti-anginal effect of propranolol in patients with coronary heart disease with angina and hypertension with "hypertrophic" type diastolic dysfunction of the left ventricle
UA102703C2 (en) Method of the estimation of efference of treatment with bisoprolol in patients suffered from ischemic heart disease with stenocardia and arterial hypertension with left ventricle hypertrophy and diastolic dysfunction
UA46778U (en) Method for assessing efficacy of bisoprolol in treatment of ischemic heart disease with stenocardia and arterial hypertension